#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Usher's syndrome Leukodystrophy HER2 mutant non-small cell lung cancer Acquired C1 inhibitor deficiency Glomerulonephritis rapidly progressive B-cell lymphoma recurrent Gastrointestinal cancer metastatic Friedreich's ataxia Ewing's sarcoma recurrent Thalassaemia Chondrodystrophy Intracranial calcification Biliary cancer metastatic Pustular psoriasis Acute respiratory distress syndrome More trials…

    Learn about Rare Diseases

    X-linked lymphoproliferative syndrome – Trials in Disease Medulloblastoma recurrent Myelodysplastic syndrome with excess blasts – Life with Disease Retinoblastoma – Trials in Disease Bronchopulmonary dysplasia – Diagnostics Waldenstrom’s macroglobulinaemia refractory – Life with Disease Rett syndrome – Life with Disease Hypereosinophilic syndrome – Basic Information Ehlers-Danlos syndrome Undifferentiated sarcoma More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Progesterone, Micronised ZODASIRAN Tafasitamab Aztreonam Oteracil Doxycycline KETOROLAC Crgd-Zw800-1 Cefoxitin Sodium Teclistamab Mva-209-Fsp-B1 Levetiracetam Olaptesed Pegol LTI-03 Adct-402 13N-AMMONIA Urapidil Artemisia Vulgaris Acp-204 Tartrate Omp11 More therapies…

    Learn about Your Condition

    Neuroblastoma Cervix carcinoma recurrent Chronic hepatitis C Diabetic foot Cutaneous calcification Hypochondroplasia Ocular hypertension Supranuclear palsy Gender dysphoria Pigmentary glaucoma Myxoid liposarcoma Short-bowel syndrome Magnetic resonance imaging Toxicity to various agents Liver transplant rejection More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. University Of Debrecen

University Of Debrecen

Mvgtys Znllpvmo Kznnu 2wy Dqmwblrgz 4kbrt Hddlmxp

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effects of Retatrutide for Patients with Obesity, Overweight, or Knee Osteoarthritis

    Not recruiting

    3 1
    Investigated Diseases:
    • Obesity
    • Osteoarthritis
    • Overweight
    Investigated Drugs:
    • Ly3437943 Sodium
    Hungary Poland Romania Spain

  • Study on Asundexian for Preventing Ischemic Stroke in Adults After a Stroke or High-Risk Mini-Stroke

    Not recruiting

    3 1
    Investigated Drugs:
    • Asundexian
    Austria Belgium Bulgaria Czechia Denmark Finland +14

  • Study on Upadacitinib for Adults and Adolescents with Moderate to Severe Hidradenitis Suppurativa After Anti-TNF Therapy Failure

    Not recruiting

    3 1
    Investigated Diseases:
    • Hidradenitis
    Investigated Drugs:
    • Upadacitinib
    Austria Belgium Bulgaria Croatia Czechia Finland +12

  • Study on the Safety and Effects of Favezelimab and Pembrolizumab for Patients with Blood Cancers

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Haematological malignancy
    Investigated Drugs:
    • Favezelimab
    • Pembrolizumab
    Germany Greece Hungary Italy

  • Study on Linaclotide for Treating Functional Constipation in Children Aged 6 Months to Less Than 2 Years

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Constipation
    Investigated Drugs:
    • Linaclotide
    Bulgaria Croatia Germany Hungary

  • Study on the Effects of LEO 138559 for Adults with Moderate-to-Severe Atopic Dermatitis

    Not recruiting

    2 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • Humanised Igg1 Monoclonal Antibody Against Interleukin 22 Receptor Subunit Alpha
    Czechia France Germany Hungary Poland Romania +1

  • Study on Upadacitinib for Children with Moderate to Severe Ulcerative Colitis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Upadacitinib
    Belgium Bulgaria Czechia France Germany Greece +5

  • Study on the Long-Term Safety and Effectiveness of Upadacitinib for Patients with Moderate to Severe Crohn’s Disease

    Not recruiting

    3 1
    Investigated Drugs:
    • Upadacitinib
    Austria Belgium Croatia Czechia Denmark France +13

  • Study on Ropeginterferon Alfa-2b for Patients with Essential Thrombocythemia Intolerant or Refractory to Other Treatments

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Thrombocytosis
    • Essential thrombocythaemia
    Investigated Drugs:
    • Ropeginterferon Alfa-2B
    Austria Czechia France Germany Greece Hungary +4

  • Study on Venetoclax, Carfilzomib, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Carfilzomib
    • Dexamethasone
    • Venetoclax
    Hungary Spain
Previous Page
1 … 41 42 43 44 45 … 52
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!